Galectin-3 and Interleukin-7 Potentially Useful as Rheumatoid Arthritis Biomarkers
Researchers examined serum galectin-3 and interleukin-7 (IL-7) levels in patients with rheumatoid arthritis and their association with disease activity.
Researchers examined serum galectin-3 and interleukin-7 (IL-7) levels in patients with rheumatoid arthritis and their association with disease activity.
Researchers evaluated the feasibility of using lung ultrasonography in screening for pleural abnormalities in children with systemic juvenile idiopathic arthritis with lung disease.
Researchers examined the incidence of temporomandibular joint disorders and craniofacial disorders in patients with juvenile idiopathic arthritis.
Researchers assessed disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flares and activity, and prolonged COVID-19 symptom duration among patients with systemic autoimmune rheumatic diseases.
Researchers assessed whether hydroxychloroquine concentration levels in patients with rheumatoid arthritis (RA) affects the incidence of COVID-19 or its complications.
Researchers investigated the association between gout and dementia in older adult patients.
Researchers assessed variability in care quality and treatment outcomes across ethnicities in early inflammatory arthritis.
Researchers assessed whether the presence of inflammation on magnetic resonance imaging differs between men and women who were overweight and obese compared with controls.
Researchers investigated the impact of time to remission, number of flares, and time on immunosuppressives after remission on estimated glomerular filtration rate in patients with lupus nephritis.
Researchers investigated whether a gout stigma exists among rheumatologists and how it influences their perceptions of patients and treatment decisions.